Abiopharma

🔍 Miranda Angie (Executive)

Company: PATRIOT NATIONAL BANCORP INC (PNBK)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 150,000 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 150,000.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 56,718 shares of Common Stock at $1.23 per share (Direct)
  Date: 2026-04-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 93,282.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Acquired 150,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | Expires: 2026-04-30 | Exercise: 2026-04-30 | equity_swap_involved: 0 | shares_owned_after: 300,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: On August 7, 2025, pursuant to an award agreement effective as of April 30, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 450,000 shares of Common Stock, which will vest in three equal installments on each of the first three anniversaries of the award date. On April 30, 2026, the first installment of 150,000 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.
• F2: Represents 56,718 shares of Common Stock withheld by the Issuer upon settlement of the RSUs to satisfy the Reporting Person's applicable tax withholding obligations. The shares were withheld at a price of $1.23 per share, representing the closing price of the Issuer's Common Stock on April 30, 2026. The withheld shares were not delivered to the Reporting Person.